EHWM
CL icon

Eads & Heald Wealth Management’s Colgate-Palmolive CL Stock Holding History

Eads & Heald Wealth Management’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Buy
21,303
+559
+3% +$49.8K 0.9% 49
2025
Q4 		$1.64M Buy
20,744
+132
+0.6% +$10.3K 0.79% 54
2025
Q3 		$1.65M Sell
20,612
-37
-0.2% -$3.16K 0.79% 55
2025
Q2 		$1.88M Buy
20,649
+89
+0.4% +$8.13K 0.93% 43
2025
Q1 		$1.93M Sell
20,560
-8
-0% -$716 0.98% 42
2024
Q4 		$1.87M Sell
20,568
-849
-4% -$81K 0.92% 43
2024
Q3 		$2.22M Sell
21,417
-1,175
-5% -$120K 1.05% 35
2024
Q2 		$2.19M Sell
22,592
-690
-3% -$63.7K 1.06% 35
2024
Q1 		$2.1M Sell
23,282
-324
-1% -$27.5K 0.98% 40
2023
Q4 		$1.88M Sell
23,606
-304
-1% -$22.9K 0.91% 47
2023
Q3 		$1.7M Sell
23,910
-488
-2% -$36.5K 0.89% 47
2023
Q2 		$1.88M Sell
24,398
-1,482
-6% -$115K 0.92% 45
2023
Q1 		$1.95M Sell
25,880
-525
-2% -$39K 0.96% 42
2022
Q4 		$2.08M Sell
26,405
-47
-0.2% -$3.52K 1.06% 37
2022
Q3 		$1.86M Buy
26,452
+297
+1% +$23.3K 1.05% 41
2022
Q2 		$2.1M Buy
26,155
+323
+1% +$25.3K 1.13% 36
2022
Q1 		$1.96M Sell
25,832
-52
-0.2% -$4.12K 0.91% 52
2021
Q4 		$2.21M Sell
25,884
-50
-0.2% -$3.9K 0.96% 45
2021
Q3 		$1.96M Buy
25,934
+160
+0.6% +$12.7K 0.95% 48
2021
Q2 		$2.1M Sell
25,774
-460
-2% -$37.6K 1.02% 39
2021
Q1 		$2.07M Buy
26,234
+219
+0.8% +$17.2K 1.06% 41
2020
Q4 		$2.23M Buy
26,015
+744
+3% +$61.5K 1.2% 28
2020
Q3 		$1.95M Sell
25,271
-1,823
-7% -$139K 1.17% 31
2020
Q2 		$1.99M Sell
27,094
-1,077
-4% -$76.5K 1.21% 29
2020
Q1 		$1.87M Sell
28,171
-1,334
-5% -$94.1K 1.32% 22
2019
Q4 		$2.03M Buy
29,505
+523
+2% +$35.7K 1.07% 42
2019
Q3 		$2.13M Buy
28,982
+56
+0.2% +$4.06K 1.19% 32
2019
Q2 		$2.07M Sell
28,926
-720
-2% -$51.1K 1.17% 32
2019
Q1 		$2.03M Buy
29,646
+554
+2% +$35.8K 1.18% 33
2018
Q4 		$1.73M Sell
29,092
-377
-1% -$23.6K 1.15% 38
2018
Q3 		$1.97M Buy
29,469
+650
+2% +$43.3K 1.13% 39
2018
Q2 		$1.87M Buy
28,819
+708
+3% +$46.3K 1.15% 35
2018
Q1 		$2.02M Buy
28,111
+240
+0.9% +$17.3K 1.28% 22
2017
Q4 		$2.1M Buy
27,871
+211
+0.8% +$15.4K 1.24% 24
2017
Q3 		$2.02M Buy
27,660
+689
+3% +$49.7K 1.25% 21
2017
Q2 		$2M Sell
26,971
-984
-4% -$73.1K 1.28% 22
2017
Q1 		$2.05M Sell
27,955
-265
-0.9% -$18.6K 1.32% 15
2016
Q4 		$1.85M Buy
28,220
+135
+0.5% +$9.26K 1.26% 20
2016
Q3 		$2.08M Sell
28,085
-533
-2% -$39.4K 1.43% 8
2016
Q2 		$2.1M Sell
28,618
-216
-0.7% -$15.4K 1.44% 8
2016
Q1 		$2.04M Sell
28,834
-1,147
-4% -$76.3K 1.41% 12
2015
Q4 		$2M Sell
29,981
-134
-0.4% -$8.91K 1.38% 17
2015
Q3 		$1.91M Sell
30,115
-580
-2% -$37.9K 1.36% 13
2015
Q2 		$2.01M Buy
30,695
+152
+0.5% +$10.3K 1.32% 16
2015
Q1 		$2.12M Sell
30,543
-764
-2% -$52.8K 1.36% 15
2014
Q4 		$2.17M Buy
31,307
+370
+1% +$25K 1.38% 14
2014
Q3 		$2.02M Sell
30,937
-888
-3% -$58.6K 1.37% 17
2014
Q2 		$2.17M Sell
31,825
-2,483
-7% -$166K 1.44% 10
2014
Q1 		$2.23M Buy
34,308
+51
+0.1% +$3.21K 1.46% 14
2013
Q4 		$2.23M Sell
34,257
-583
-2% -$37.3K 1.48% 13
2013
Q3 		$2.07M Sell
34,840
-2,462
-7% -$146K 1.48% 10
2013
Q2 		$2.14M Buy
+37,302
New +$2.21M 1.51% 10

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Eads & Heald Wealth Management's CL Position: Q1 2026 in Review

Eads & Heald Wealth Management increased its Colgate-Palmolive (CL) stake by 2.7% in Q1 2026, buying an estimated $49.8K and bringing the position to 21,303 shares worth $1.82M. The position accounts for 0.9% of the portfolio, ranked #49.

Eads & Heald Wealth Management first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.23M in Q4 2013. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Eads & Heald Wealth Management held 21,303 shares of Colgate-Palmolive worth $1.82M as of Q1 2026.
  • Eads & Heald Wealth Management bought 559 Colgate-Palmolive shares in Q1 2026, an estimated $49.8K.
  • Colgate-Palmolive made up 0.9% of Eads & Heald Wealth Management's portfolio in Q1 2026, its #49 holding.
  • Eads & Heald Wealth Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Eads & Heald Wealth Management's Colgate-Palmolive position peaked at $2.23M in Q4 2013.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Eads & Heald Wealth Management's 13F filing for Q1 2026, filed 29 Apr 2026.